ALLMedicine™ Mumps Center

May 6th, 2021 - Recently there has been a significant increase in the number of mumps outbreaks occurring in highly vaccinated populations. These outbreaks are often due to a mumps genotype G virus, where sequencing of the SH gene does not reveal enough genetic d...

May 6th, 2021 - Evidence on vaccine effectiveness (VE) may encourage vaccination and help fight the reemergence of measles and mumps in Europe. However, limited data exist on real-life effectiveness of individual measles, mumps and rubella (MMR) vaccines. This st...

Apr 25th, 2021 - Determining dynamics of maternally transferred antibodies against measles, mumps and rubella infections in infants is important for making evidence -based policy decisions for the timing of vaccination. Serum immunoglobulin G (IgG) levels, develop...

Apr 20th, 2021 - In Japan, monovalent vaccine against mumps virus (MuV) infection was shifted to a voluntary basis vaccination due to the incidences of aseptic meningitis in the past. According to an analysis of a total of 409 participants aged 18-20 years, overal...

Apr 16th, 2021 - We assessed the 10-year efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine (MMRV) or one dose of a monovalent varicella vaccine (V) in children from Czech Republic, Lithuania, Poland, Romania and...

Oct 3rd, 2019 - What is already known about this topic? Measles was eliminated in the United States in 2000. High national coverage with measles, mumps, and rubella vaccine and rapid implementation of measles control measures prevent widespread measles transmiss...

Apr 14th, 2019 - Measles, Also Known As Rubeola, Is A Highly Contagious Airborne Viral Illness That Infects Approximately Nine Out Of Ten Exposed Susceptible Individuals. Measles Infection Was Common Until The Measles, Mumps, And Rubella (MMR) Vaccine Was Licensed...

Mar 14th, 2019 - Mumps is a viral illness caused by a paramyxovirus, a member of the Rubulavirus family. The average incubation period for mumps is 16 to 18 days, with a range of 12 to 25 days.

Mar 6th, 2018 - The Advisory Committee on Immunization Practices made relatively few new vaccine recommendations in 2017. One pertained to prevention of hepatitis B virus infection in infants born to HBV-infected mothers. Another recommended a new vaccine to prev...

Mar 9th, 2017 - Immunity to a disease is achieved through the presence of antibodies to that disease in a person’s system. Antibodies are proteins produced by the body to neutralize or destroy toxins or disease-carrying organisms. Antibodies are disease-specific....

May 6th, 2021 - Recently there has been a significant increase in the number of mumps outbreaks occurring in highly vaccinated populations. These outbreaks are often due to a mumps genotype G virus, where sequencing of the SH gene does not reveal enough genetic d...

May 6th, 2021 - Evidence on vaccine effectiveness (VE) may encourage vaccination and help fight the reemergence of measles and mumps in Europe. However, limited data exist on real-life effectiveness of individual measles, mumps and rubella (MMR) vaccines. This st...

Apr 25th, 2021 - Determining dynamics of maternally transferred antibodies against measles, mumps and rubella infections in infants is important for making evidence -based policy decisions for the timing of vaccination. Serum immunoglobulin G (IgG) levels, develop...

Apr 20th, 2021 - In Japan, monovalent vaccine against mumps virus (MuV) infection was shifted to a voluntary basis vaccination due to the incidences of aseptic meningitis in the past. According to an analysis of a total of 409 participants aged 18-20 years, overal...

Apr 16th, 2021 - We assessed the 10-year efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine (MMRV) or one dose of a monovalent varicella vaccine (V) in children from Czech Republic, Lithuania, Poland, Romania and...

Mar 9th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Polls show Americans are increasingly interested in getting vaccinated against COVID-19, but such surveys are largely national, leaving a big ques...

Dec 27th, 2020 - NEW YORK (Reuters Health) - Many children under age two did not receive the measles-mumps-rubella (MMR) vaccine or preventive care visits even after clinics reopened following pandemic-related closures in a multicenter primary care network. The mo...

Dec 14th, 2020 - After an initial drop at the time of introduction of social distancing measures in March 2020, hexavalent (DTaP/IPV/Hib/HepB) and measles, mumps and rubella (MMR) vaccination counts have almost reached pre-COVID-19 levels, according to the latest ...

Nov 22nd, 2020 - (Reuters) - People whose immune systems responded strongly to a measles-mumps-rubella (MMR) vaccine may be less likely to become severely ill if they are infected with the new coronavirus, new data suggest. The MMR II vaccine, manufactured by Merc...

May 18th, 2020 - FILE PHOTO: A vial of measles, mumps and rubella vaccine and an information sheet is seen at Boston Children's Hospital in Boston, Massachusetts February 26, 2015. REUTERS/Brian Snyder/File Photo (Reuters) - Researchers have documented a drop in c...